|
1
|
Beekman R, Chapaprieta V, Russiñol N,
Vilarrasa-Blasi R, Verdaguer-Dot N, Martens JHA, Duran-Ferrer M,
Kulis M, Serra F, Javierre BM, et al: The reference epigenome and
regulatory chromatin landscape of chronic lymphocytic leukemia. Nat
Med. 24:868–880. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Oakes CC, Seifert M, Assenov Y, Gu L,
Przekopowitz M, Ruppert AS, Wang Q, Imbusch CD, Serva A, Koser SD,
et al: DNA methylation dynamics during B cell maturation underlie a
continuum of disease phenotypes in chronic lymphocytic leukemia.
Nat Genet. 48:253–264. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ten Hacken E and Burger JA:
Microenvironment interactions and B-cell receptor signaling in
Chronic Lymphocytic Leukemia: Implications for disease pathogenesis
and treatment. Biochim Biophys Acta. 1863:401–413. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nadeu F, Clot G, Delgado J, Martín-García
D, Baumann T, Salaverria I, Beà S, Pinyol M, Jares P, Navarro A, et
al: Clinical impact of the subclonal architecture and mutational
complexity in chronic lymphocytic leukemia. Leukemia. 32:645–653.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nadeu F, Diaz-Navarro A, Delgado J, Puente
XS and Campo E: Genomic and epigenomic alterations in chronic
lymphocytic leukemia. Annu Rev Pathol Mech Dis. 15:149–177. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baliakas P, Moysiadis T, Hadzidimitriou A,
Xochelli A, Jeromin S, Agathangelidis A, Mattsson M, Sutton LA,
Minga E, Scarfò L, et al: Tailored approaches grounded on
immunogenetic features for refined prognostication in chronic
lymphocytic leukemia. Haematologica. 104:360–369. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stevenson FK, Forconi F and Kipps TJ:
Exploring the pathways to chronic lymphocytic leukemia. Blood.
138:827–835. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hilal T, Gea-Banacloche JC and Leis JF:
Chronic lymphocytic leukemia and infection risk in the era of
targeted therapies: Linking mechanisms with infections. Blood Rev.
32:387–399. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Benckert J, Schmolka N, Kreschel C, Zoller
MJ, Sturm A, Wiedenmann B and Wardemann H: The majority of
intestinal IgA+ and IgG+ plasmablasts in the human gut are
antigen-specific. J Clin Invest. 121:1946–1955. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jain T, Sharma P, Are AC, Vickers SM and
Dudeja V: New insights into the cancer-microbiome-immune axis:
Decrypting a decade of discoveries. Front Immunol. 12:6220642021.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng D, Liwinski T and Elinav E:
Interaction between microbiota and immunity in health and disease.
Cell Res. 30:492–506. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wlasiuk P, Niedzielski A, Skorka K,
Karczmarczyk A, Zaleska J, Zajac M, Putowski M, Pac-Kozuchowska E
and Giannopoulos K: Accumulation of CD5+CD19+
B lymphocytes expressing PD-1 and PD-1L in hypertrophied pharyngeal
tonsils. Clin Exp Med. 16:503–509. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yuan D, Tao Y, Wang H, Wang J, Cao Y, Cao
W, Pan S and Yu Z: A comprehensive analysis of the microbiota
composition and host driver gene mutations in colorectal cancer.
Invest New Drugs. 40:884–894. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lazar V, Ditu LM, Pircalabioru GG,
Gheorghe I, Curutiu C, Holban AM, Picu A, Petcu L and Chifiriuc MC:
Aspects of gut microbiota and immune system interactions in
infectious diseases, immunopathology, and cancer. Front Immunol.
9:18302018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bai L, Zhou P, Li D and Ju X: Changes in
the gastrointestinal microbiota of children with acute
lymphoblastic leukaemia and its association with antibiotics in the
short term. J Med Microbiol. 66:1297–1307. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nearing JT, Connors J, Whitehouse S, Van
Limbergen J, Macdonald T, Kulkarni K and Langille MGI: Infectious
complications are associated with alterations in the gut microbiome
in pediatric patients with acute lymphoblastic leukemia. Front Cell
Infect Microbiol. 9:282019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Galloway-Peña JR, Smith DP, Sahasrabhojane
P, Ajami NJ, Wadsworth WD, Daver NG, Chemaly RF, Marsh L, Ghantoji
SS, Pemmaraju N, et al: The role of the gastrointestinal microbiome
in infectious complications during induction chemotherapy for acute
myeloid leukemia. Cancer. 122:2186–2196. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang R, Yang X, Liu J, Zhong F, Zhang C,
Chen Y, Sun T, Ji C and Ma D: Gut microbiota regulates acute
myeloid leukaemia via alteration of intestinal barrier function
mediated by butyrate. Nat Commun. 13:25222022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Faitová T, Svanberg R, Da Cunha-Bang C,
Ilett EE, Jørgensen M, Noguera-Julian M, Paredes R, MacPherson CR
and Niemann CU: The gut microbiome in patients with chronic
lymphocytic leukemia. Haematologica. 107:2238–2243. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gopalakrishnan V, Spencer CN, Nezi L,
Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman
K, Wei SC, et al: Gut microbiome modulates response to anti-PD-1
immunotherapy in melanoma patients. Science. 359:97–103. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Viaud S, Saccheri F, Mignot G, Yamazaki T,
Daillère R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ,
et al: The intestinal microbiota modulates the anticancer immune
effects of cyclophosphamide. Science. 342:971–976. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Uribe-Herranz M, Rafail S, Beghi S,
Gil-de-Gómez L, Verginadis I, Bittinger K, Pustylnikov S, Pierini
S, Perales-Linares R, Blair IA, et al: Gut microbiota modulate
dendritic cell antigen presentation and radiotherapy-induced
antitumor immune response. J Clin Invest. 130:466–479. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Routy B, Le Chatelier E, Derosa L, Duong
CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C,
Roberti MP, et al: Gut microbiome influences efficacy of PD-1-based
immunotherapy against epithelial tumors. Science. 359:91–97. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pal K, Bystry V, Reigl T, Demko M, Krejci
A, Touloumenidou T, Stalika E, Tichy B, Ghia P, Stamatopoulos K, et
al: GLASS: Assisted and standardized assessment of gene variations
from Sanger sequence trace data. Bioinformatics. 33:3802–3804.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Malcikova J, Tausch E, Rossi D, Sutton LA,
Soussi T, Zenz T, Kater AP, Niemann CU, Gonzalez D, Davi F, et al:
ERIC recommendations for TP53 mutation analysis in chronic
lymphocytic leukemia-update on methodological approaches and
results interpretation. Leukemia. 32:1070–1080. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
van Dongen JJM, Langerak AW, Brüggemann M,
Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E,
García-Sanz R, et al: Design and standardization of PCR primers and
protocols for detection of clonal immunoglobulin and T-cell
receptor gene recombinations in suspect lymphoproliferations:
Report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia.
17:2257–2317. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Giudicelli V, Brochet X and Lefranc MP:
IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG)
and T cell receptor (TR) nucleotide sequences. Cold Spring Harb
Protoc. 2011:695–715. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brochet X, Lefranc M-P and Giudicelli V:
IMGT/V-QUEST: The highly customized and integrated system for IG
and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids
Res. 36:W503–W508. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rosenquist R, Ghia P, Hadzidimitriou A,
Sutton LA, Agathangelidis A, Baliakas P, Darzentas N, Giudicelli V,
Lefranc MP, Langerak AW, et al: Immunoglobulin gene sequence
analysis in chronic lymphocytic leukemia: updated ERIC
recommendations. Leukemia. 31:1477–1481. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bystry V, Agathangelidis A, Bikos V,
Sutton LA, Baliakas P, Hadzidimitriou A, Stamatopoulos K and
Darzentas N; European Research Initiative on CLL, :
ARResT/AssignSubsets: A novel application for robust
subclassification of chronic lymphocytic leukemia based on B cell
receptor IG stereotypy. Bioinformatics. 31:3844–3846. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Andrews S: FastQC: A quality control tool
for high throughput sequence data. www.bioinformatics.babraham.ac.uk/projects/fastqc21–Feb.
2023
|
|
32
|
Li H: Seqtk: Toolkit for processing
sequences in FASTA/Q formats. github.com/lh3/seqtk21–Feb. 2023
|
|
33
|
Quast C, Pruesse E, Yilmaz P, Gerken J,
Schweer T, Yarza P, Peplies J and Glöckner FO: The SILVA ribosomal
RNA gene database project: Improved data processing and web-based
tools. Nucleic Acids Res. 41:D590–D596. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Callahan BJ, McMurdie PJ, Rosen MJ, Han
AW, Johnson AJA and Holmes SP: DADA2: High-resolution sample
inference from Illumina amplicon data. Nat Methods. 13:581–583.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nguyen LT, Schmidt HA, von Haeseler A and
Minh BQ: IQ-TREE: A fast and effective stochastic algorithm for
estimating maximum-likelihood phylogenies. Mol Biol Evol.
32:268–274. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
McMurdie PJ and Holmes S: Phyloseq: An R
package for reproducible interactive analysis and graphics of
microbiome census data. PLoS One. 8:e612172013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lahti L and Shetty S: Tools for microbiome
analysis in R. Microbiome package version 1.23.1.
github.com/microbiome. 21–Feb. 2023
|
|
38
|
Shetty S and Lahti L: Microbiomeutilities:
Utilities for microbiome analytics.
github.com/microsud/microbiomeutilities. 21–Feb. 2023
|
|
39
|
Guo K and Gao P: Microbal-an R package for
microbial community analysis with dada2 and phyloseq.
github.com/guokai8/microbial. 21–Feb. 2023
|
|
40
|
Barnett D, Arts I and Penders J: microViz:
An R package for microbiome data visualization and statistics. J
Open Source Softw. 6:32012021. View Article : Google Scholar
|
|
41
|
Kembel SW, Cowan PD, Helmus MR, Cornwell
WK, Morlon H, Ackerly DD, Blomberg SP and Webb CO: Picante: R tools
for integrating phylogenies and ecology. Bioinformatics.
26:1463–1464. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lozupone CA and Knight R: The unifrac
significance test is sensitive to tree topology. BMC
Bioinformatics. 16:2112015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bray JR and Curtis JT: An ordination of
the upland forest communities of southern Wisconsin. Ecol Monogr.
27:325–349. 1957. View Article : Google Scholar
|
|
44
|
Oksanen J, Simpson G, Blanchet F, Kindt R,
Legendre P, Minchin PR, O'Hara RB, Solymos P, Stevens HH, Szoecs E,
et al: Vegan: Community ecology package. R package version 2.6–7.
github.com/vegandevs/vegan. 21–Feb. 2023
|
|
45
|
Segata N, Izard J, Waldron L, Gevers D,
Miropolsky L, Garrett WS and Huttenhower C: Metagenomic biomarker
discovery and explanation. Genome Biol. 12:R602011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Allignol A and Latouche A: CRAN task view:
Survival analysis. github.com/cran-task-views/Survival. 21–Feb.
2023
|
|
47
|
Hothorn T: maxstat: Maximally selected
rank statistics. rdrr.io/cran/maxstat. 21–Feb. 2023
|
|
48
|
Kassambara A: survminer R package:
Survival analysis and visualization.
github.com/kassambara/survminer. 21–Feb. 2023
|
|
49
|
RStudio Team, . RStudio: Integrated
development environment for R. www.rstudio.com
|
|
50
|
Kawari M, Akhtar M, Sager M, Basbous Z,
Baydoun I, Kabanja J, Darweesh M, Mokhtar N, Kanfar S, Mutahar E,
et al: Alterations of gut microbiome in untreated chronic
lymphocytic leukemia (CLL); future therapeutic potentials. Blood.
134:5455. 2019. View Article : Google Scholar
|
|
51
|
Shi Z and Zhang M: Emerging roles for the
gut microbiome in lymphoid neoplasms. Clin Med Insights Oncol.
15:1179554921102412021. View Article : Google Scholar
|
|
52
|
Madhogaria B, Bhowmik P and Kundu A:
Correlation between human gut microbiome and diseases. Infect Med.
1:180–191. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
An J, Kwon H and Kim YJ: The
Firmicutes/bacteroidetes ratio as a risk factor of breast cancer. J
Clin Med. 12:22162023. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Khorsand B, Asadzadeh Aghdaei H,
Nazemalhosseini-Mojarad E, Nadalian B, Nadalian B and Houri H:
Overrepresentation of Enterobacteriaceae and Escherichia
coli is the major gut microbiome signature in Crohn's disease
and ulcerative colitis; a comprehensive metagenomic analysis of
IBDMDB datasets. Front Cell Infect Microbiol. 12:10158902022.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mirpuri J, Raetz M, Sturge CR, Wilhelm CL,
Benson A, Savani RC, Hooper LV and Yarovinsky F:
Proteobacteria-specific IgA regulates maturation of the intestinal
microbiota. Gut Microbes. 5:28–39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Hajishengallis G and Lambris JD: Microbial
manipulation of receptor crosstalk in innate immunity. Nat Rev
Immunol. 11:187–200. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Kawai T and Akira S: The role of
pattern-recognition receptors in innate immunity: Update on
Toll-like receptors. Nat Immunol. 11:373–384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ferrer G and Montserrat E: Critical
molecular pathways in CLL therapy. Mol Med. 24:92018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yuan L, Wang W, Zhang W, Zhang Y, Wei C,
Li J and Zhou D: Gut microbiota in untreated diffuse large B cell
lymphoma patients. Front Microbiol. 12:6463612021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Jian X, Zhu Y, Ouyang J, Wang Y, Lei Q,
Xia J, Guan Y, Zhang J, Guo J, He Y, et al: Alterations of gut
microbiome accelerate multiple myeloma progression by increasing
the relative abundances of nitrogen-recycling bacteria. Microbiome.
8:742020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Mirzaei R, Afaghi A, Babakhani S, Sohrabi
MR, Hosseini-Fard SR, Babolhavaeji K, Khani Ali Akbari S,
Yousefimashouf R and Karampoor S: Role of microbiota-derived
short-chain fatty acids in cancer development and prevention.
Biomed Pharmacother. 139:1116192021. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Kim CH: Control of lymphocyte functions by
gut microbiota-derived short-chain fatty acids. Cell Mol Immunol.
18:1161–1171. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Singh N, Thangaraju M, Prasad PD, Martin
PM, Lambert NA, Boettger T, Offermanns S and Ganapathy V: Blockade
of dendritic cell development by bacterial fermentation products
butyrate and propionate through a transporter (Slc5a8)-dependent
inhibition of histone deacetylases. J Biol Chem. 285:27601–27608.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Rosser EC, Piper CJM, Matei DE, Blair PA,
Rendeiro AF, Orford M, Alber DG, Krausgruber T, Catalan D, Klein N,
et al: Microbiota-derived metabolites suppress arthritis by
amplifying aryl-hydrocarbon receptor activation in regulatory B
cells. Cell Metab. 31:837–851.e10. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Park J, Kim M, Kang SG, Jannasch AH,
Cooper B, Patterson J and Kim CH: Short-chain fatty acids induce
both effector and regulatory T cells by suppression of histone
deacetylases and regulation of the mTOR-S6K pathway. Mucosal
Immunol. 8:80–93. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zimmerman MA, Singh N, Martin PM,
Thangaraju M, Ganapathy V, Waller JL, Shi H, Robertson KD, Munn DH
and Liu K: Butyrate suppresses colonic inflammation through
HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T
cells. Am J Physiol Liver Physiol. 302:G1405–G1415. 2012.PubMed/NCBI
|
|
67
|
Bailón E, Cueto-Sola M, Utrilla P,
Rodríguez-Cabezas ME, Garrido-Mesa N, Zarzuelo A, Xaus J, Gálvez J
and Comalada M: Butyrate in vitro immune-modulatory effects might
be mediated through a proliferation-related induction of apoptosis.
Immunobiology. 215:863–873. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Griggio V, Perutelli F, Salvetti C,
Boccellato E, Boccadoro M, Vitale C and Coscia M: Immune
dysfunctions and immune-based therapeutic interventions in chronic
lymphocytic leukemia. Front Immunol. 11:5945562020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Rogers MAM and Aronoff DM: The influence
of non-steroidal anti-inflammatory drugs on the gut microbiome.
Clin Microbiol Infect. 22:178.e1–178.e9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zheng T and Marques FZ: Gut microbiota:
Friends or foes for blood pressure-lowering drugs. Hypertension.
79:1602–1604. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Minichino A, Preston T, Fanshawe JB,
Fusar-Poli P, McGuire P, Burnet PWJ and Lennox BR:
Psycho-pharmacomicrobiomics: A systematic review and meta-analysis.
Biol Psychiatry. 95:611–628. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Statovci D, Aguilera M, MacSharry J and
Melgar S: The impact of Western diet and nutrients on the
microbiota and immune response at mucosal interfaces. Front
Immunol. 8:8382017. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Gupta VK, Paul S and Dutta C: Geography,
ethnicity or subsistence-specific variations in human microbiome
composition and diversity. Front Microbiol. 8:11622017. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Fernández-Pato A, Sinha T, Gacesa R,
Andreu-Sánchez S, Gois MFB, Gelderloos-Arends J, Jansen DBH, Kruk
M, Jaeger M, Joosten LAB, et al: Choice of DNA extraction method
affects stool microbiome recovery and subsequent phenotypic
association analyses. Sci Rep. 14:39112024. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
González A, Fullaondo A and Odriozola A:
Techniques, procedures, and applications in microbiome analysis.
pp81–115. 2024.
|
|
76
|
Pianko MJ, Devlin SM, Littmann ER,
Chansakul A, Mastey D, Salcedo M, Fontana E, Ling L, Tavitian E,
Slingerland JB, et al: Minimal residual disease negativity in
multiple myeloma is associated with intestinal microbiota
composition. Blood Adv. 3:2040–2044. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Peled JU, Devlin SM, Staffas A, Lumish M,
Khanin R, Littmann ER, Ling L, Kosuri S, Maloy M, Slingerland JB,
et al: Intestinal microbiota and relapse after hematopoietic-cell
transplantation. J Clin Oncol. 35:1650–1659. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Yoon SE, Kang W, Chalita M, Lim J, Kim WS
and Kim SJ: Comprehensive understanding of gut microbiota in
treatment naïve diffuse large B cell lymphoma patients. Blood.
138:2409. 2021. View Article : Google Scholar
|
|
79
|
Ruth MR and Field CJ: The immune modifying
effects of amino acids on gut-associated lymphoid tissue. J Anim
Sci Biotechnol. 4:272013. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Ma L, Ni Y, Wang Z, Tu W, Ni L, Zhuge F,
Zheng A, Hu L, Zhao Y, Zheng L and Fu Z: Spermidine improves gut
barrier integrity and gut microbiota function in diet-induced obese
mice. Gut Microbes. 12:18328572020. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Nakamura A, Kurihara S, Takahashi D,
Ohashi W, Nakamura Y, Kimura S, Onuki M, Kume A, Sasazawa Y,
Furusawa Y, et al: Symbiotic polyamine metabolism regulates
epithelial proliferation and macrophage differentiation in the
colon. Nat Commun. 12:21052021. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Lai HC, Chang CJ, Yang CH, Hsu YJ, Chen
CC, Lin CS, Tsai YH, Huang TT, Ojcius DM, Tsai YH and Lu CC:
Activation of NK cell cytotoxicity by the natural compound
2,3-butanediol. J Leukoc Biol. 92:807–814. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Faitova T, Coelho M, Da Cunha-Bang C,
Ozturk S, Kartal E, Bork P, Seiffert M and Niemann CU: The
diversity of the microbiome impacts chronic lymphocytic leukemia
development in mice and humans. Haematologica. May 9–2024.doi:
10.3324/haematol.2023.284693 (Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Akimbekov NS, Digel I, Yerezhepov AY,
Shardarbek RS, Wu X and Zha J: Nutritional factors influencing
microbiota-mediated colonization resistance of the oral cavity: A
literature review. Front Nutr. 9:10293242022. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Kilian M, Chapple ILC, Hannig M, Marsh PD,
Meuric V, Pedersen AM, Tonetti MS, Wade WG and Zaura E: The oral
microbiome-an update for oral healthcare professionals. Br Dent J.
221:657–666. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Tan X, Wang Y and Gong T: The interplay
between oral microbiota, gut microbiota and systematic diseases. J
Oral Microbiol. 15:22131122023. View Article : Google Scholar : PubMed/NCBI
|
